Non-viral genetic medicines

Search documents
enGene Holdings (ENGN) 2025 Conference Transcript
2025-06-04 16:07
enGene Holdings (ENGN) 2025 Conference June 04, 2025 11:05 AM ET Speaker0 Well, thank you very much. It's a delight to be here, and I'm grateful for this opportunity to speak about NGIN, which is a non viral genetic medicines company that's at a very important stage in our life cycle. I'm looking forward to sharing more about that with all of you. So again, thank you to the conference organizers for this opportunity. As you will expect, I'm gonna be making some forward looking statements during today's pres ...
enGene(ENGN) - 2025 FY - Earnings Call Transcript
2025-02-11 14:40
enGene Holdings (ENGN) FY 2025 Conference February 11, 2025 08:40 AM ET Company Participants Alex Nichols - Chief Strategy & Operations OfficerRyan Daws - CFO Conference Call Participants Leland Gershell - Managing Director - Senior Biotechnology Analyst Leland Gershell Great. Good morning, everyone, or good afternoon, depending where you may be. Welcome back to another session here at, Oppenheimer's thirty fifth annual, Healthcare Life Sciences annual conference. I'm Leland Grischell, one of the biotech an ...